New radiotherapy technique could revolutionise cancer therapy
The Paul Scherrer Institute (PSI) has tested a new ultrafast, high-dose radiation technique using protons that scientists say could revolutionise cancer therapy and save patients many weeks of treatment.
This content was published on
2 minutes
Paul Scherrer Institute/sb
Español
es
Nueva radioterapia revolucionaría tratamiento del cáncer
Researchers at PSI’s Centre for Proton Therapy (CPT) in Villigen, northern Switzerland, are investigating whether a short, one-off, high-dose irradiation technique, known as FLASH, is also suitable for proton irradiation. It relies on a precise 3D radiation treatment developed at the institute called spot-scanningExternal link.
In a world first, PSI researchers, in collaboration with Lausanne University Hospital (CHUV), have tested the technique on a patient to treat a malignant skin tumour, the institute said in a statementExternal link on Monday.
With FLASH, a radiation dose rate of up to 1,000 gray per second is applied – around 100 times higher than in usual treatments. The test was approved by the Swiss Academy of Medical Sciences (SAMS).
During the trial the CHUV researchers used electron beams for the patient test, which are only suitable for very superficial tumours. In contrast, the protons used at PSI also reach tumours deep inside the body and can be stopped precisely at the site in the body where they should have their maximum effect on the cancer cells.
“If we can achieve the high precision and the good outcome of proton therapy with FLASH irradiation without damaging healthy tissue, this would be a huge step forward,” said CPT head and chief physician Damien Weber.
“If the principle works, the patients would only have to come for radiation treatment a few times, ideally only one to five times. The treatment appointments that open up as a result would be available to other cancer patients.”
More tests
Because of the extremely short irradiation, it is even possible to use the FLASH technique to treat tissue in the lungs, PSI said.
However, many years of technical development and tests are still needed before the process can be used regularly on patients, the institute added.
“But first and foremost, we need evidence that proton irradiation with the FLASH technique does not damage healthy body tissue,” said Weber.
Popular Stories
More
Workplace Switzerland
What lies ahead for Switzerland: an economic outlook for 2025
Have you heard something about Swiss diplomacy that you’d like us to fact check?
Not all information circulating about Switzerland’s foreign relations is accurate or well understood. Tell us what you'd like us to fact check or clarify.
Swiss man faces life imprisonment after Australia drugs arrest
This content was published on
Swiss man, 21, accused of attempting to smuggle 25 kilograms of cocaine with a street value of CHF4.5 million into Australia.
Swiss insurer Helvetia says 500 jobs affected by cost-cutting
This content was published on
Some 500 jobs, including 200 to 250 in Switzerland, are affected by the new operational efficiency measures recently announced by insurer Helvetia.
This content was published on
Significantly fewer new cars were sold in Switzerland in 2024 than the previous year as demand for electric cars and plug-in hybrids declined.
Three Swiss brands among world’s 100 most valuable firms
This content was published on
Three Swiss firms made it into the 2024 top 100 most valuable companies in the world, despite Roche, Nestlé and Novartis falling down the rankings.
This content was published on
Swiss singer Bernie Constantin, who made a name for himself with the 1980s songs 'Switzerland Reggae' and 'Lola Berlingo' has died aged 77.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Precision Medicine: A game changer for brain and mental health
This content was published on
Cancer patients benefit from precision medicine, but we must invest in a personalised approach to treating neurological disease such as Alzheimer’s.
Swiss researchers decode cell receptor in cancer metastasis
This content was published on
Researchers in Switzerland have deciphered the structure of a cell receptor, unlocking new hope for the prevention of metastasis of certain cancers.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.